European Equities Traded in the US as American Depositary Receipts Track Lower in Wednesday Trading

  • Facebook.
  • Twitter.
  • LinkedIn.
  • Print

11:03 AM EDT, 03/19/2025 (MT Newswires) -- European equities traded in the US as American depositary receipts were lower late Wednesday morning, declining 0.36% to 1,442.32 on the S&P Europe Select ADR Index.

From continental Europe, the gainers were led by semiconductor company Sequans Communications ( SQNS ) and internet browser company Opera (OPRA), which rose 3.6% each. They were followed by 3D printer company Materialise (MTLS) and petroleum refiner Equinor ( EQNR ) , which were up 2.2% and 1.9% respectively.

The decliners from continental Europe were led by biopharmaceutical company DBV Technologies ( DBVT ) and financial services company Banco Bilbao Vizcaya Argentaria ( BBVA ) , which fell 2.5% and 2.1% respectively. They were followed by pharmaceutical companies Ascendis Pharma ( ASND ) and Novo Nordisk ( NVO ) , which were down 1.8% and 1.3% respectively.

From the UK and Ireland, the gainers were led by biopharmaceutical companies Biodexa Pharmaceuticals ( BDRX ) and Akari Therapeutics ( AKTX ) , which advanced 25% and 5% respectively. They were followed by biopharmaceutical company Amarin ( AMRN ) and cruise line operator Carnival (CUK), which increased 4.9% and 3.1% respectively.

The decliners from the UK and Ireland were led by biopharmaceutical company NuCana ( NCNA ) and biotech firm Trinity Biotech ( TRIB ) , which dropped 3.5% and 2.8% respectively. They were followed by pharmaceutical company GSK (GSK) and medical device maker Smith & Nephew ( SNN ) , which lost 1.9% and 1.7% respectively.

MT Newswires does not provide investment advice. Unauthorized reproduction is strictly prohibited.

© 1999-2025 Midnight Trader, Inc. All rights reserved.

  • Facebook.
  • Twitter.
  • LinkedIn.
  • Print
close
Please enter a valid e-mail address
Please enter a valid e-mail address
Important legal information about the e-mail you will be sending. By using this service, you agree to input your real e-mail address and only send it to people you know. It is a violation of law in some jurisdictions to falsely identify yourself in an e-mail. All information you provide will be used by Fidelity solely for the purpose of sending the e-mail on your behalf.The subject line of the e-mail you send will be "Fidelity.com: "

Your e-mail has been sent.
close

Your e-mail has been sent.